(GIL) Gildan Activewear - Overview
Sector: Consumer Cyclical | Industry: Apparel Manufacturing | Exchange: NYSE (USA) | Market Cap: 10.461m USD | Total Return: 21% in 12m
Avg Turnover: 53.7M
EPS Trend: 97.3%
Qual. Beats: -1
Rev. Trend: 82.5%
Qual. Beats: 0
Warnings
Share dilution 21.8% YoY
Tailwinds
No distinct edge detected
Gildan Activewear Inc. (GIL) is a Montreal-based manufacturer and distributor of basic apparel, specializing in activewear, hosiery, and underwear. The company operates a vertically integrated business model, controlling most of its manufacturing process from yarn spinning to finished garment assembly. Its portfolio includes internal brands such as Gildan, American Apparel, and Comfort Colors, alongside licensed brands like Polo Ralph Lauren and Under Armour.
The company primarily serves the printwear market, selling undecorated blanks to wholesale distributors and screenprinters who customize the products for resale. This business model relies on high-volume production and economies of scale within the apparel manufacturing sector to maintain competitive pricing. Gildan distributes its products globally across North America, Europe, Asia-Pacific, and Latin America through various retail and wholesale channels.
Investors can examine the companys historical valuation trends and profitability metrics on ValueRay. Gildans operations are supported by a network of large-scale manufacturing facilities located primarily in Central America and the Caribbean Basin to optimize labor and logistics costs.
- Cotton price volatility significantly impacts raw material costs and operating margins
- Global printwear demand fluctuations drive wholesale revenue for blank apparel products
- Manufacturing capacity expansion in low-cost regions influences long-term capital efficiency
- Shifts in consumer discretionary spending affect retail hosiery and underwear sales volumes
- Strategic brand licensing agreements and private label partnerships determine market share growth
| Net Income: 249.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -3.41 > 1.0 |
| NWC/Revenue: 67.48% < 20% (prev 46.97%; Δ 20.51% < -1%) |
| CFO/TA 0.04 > 3% & CFO 452.8m > Net Income 249.2m |
| Net Debt (5.07b) to EBITDA (631.4m): 8.03 < 3 |
| Current Ratio: 2.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (185.2m) vs 12m ago 21.82% < -2% |
| Gross Margin: 28.93% > 18% (prev 0.31%; Δ 2.86k% > 0.5%) |
| Asset Turnover: 56.83% > 50% (prev 83.90%; Δ -27.07% > 0%) |
| Interest Coverage Ratio: 2.93 > 6 (EBITDA TTM 631.4m / Interest Expense TTM 157.7m) |
| A: 0.26 (Total Current Assets 4.81b - Total Current Liabilities 2.05b) / Total Assets 10.5b |
| B: 0.10 (Retained Earnings 1.00b / Total Assets 10.5b) |
| C: 0.06 (EBIT TTM 462.1m / Avg Total Assets 7.20b) |
| D: 0.47 (Book Value of Equity 3.34b / Total Liabilities 7.07b) |
| Altman-Z'' = 2.97 = A |
| DSRI: 1.23 (Receivables 1.01b/662.1m, Revenue 4.09b/3.29b) |
| GMI: 1.06 (GM 28.93% / 30.77%) |
| AQI: 2.54 (AQ_t 0.38 / AQ_t-1 0.15) |
| SGI: 1.24 (Revenue 4.09b / 3.29b) |
| TATA: -0.02 (NI 249.2m - CFO 452.8m) / TA 10.5b) |
| Beneish M = -1.71 (Cap -4..+1) = CCC |
As of May 24, 2026, the stock is trading at USD 58.15 with a total of 1,137,278 shares traded.
Over the past week, the price has changed by +3.46%,
over one month by -3.78%,
over three months by -16.98% and
over the past year by +20.96%.
Gildan Activewear has received a consensus analysts rating of 4.38. Therefore, it is recommended to buy GIL.
- StrongBuy: 6
- Buy: 6
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 83.2 | 43.1% |
P/E Forward = 13.9082
P/S = 2.568
P/B = 3.2202
P/EG = 0.4855
Revenue TTM = 4.09b USD
EBIT TTM = 462.1m USD
EBITDA TTM = 631.4m USD
Long Term Debt = 4.27b USD (from longTermDebt, last quarter)
Short Term Debt = 509.4m USD (from shortTermDebt, last quarter)
Debt = 5.31b USD (from shortLongTermDebtTotal, last quarter) + Leases 296.7m
Net Debt = 5.07b USD (calculated: Debt 5.31b - CCE 237.1m)
Enterprise Value = 15.5b USD (10.5b + Debt 5.31b - CCE 237.1m)
Interest Coverage Ratio = 2.93 (Ebit TTM 462.1m / Interest Expense TTM 157.7m)
EV/FCF = 46.03x (Enterprise Value 15.5b / FCF TTM 337.4m)
FCF Yield = 2.17% (FCF TTM 337.4m / Enterprise Value 15.5b)
FCF Margin = 8.25% (FCF TTM 337.4m / Revenue TTM 4.09b)
Net Margin = 6.10% (Net Income TTM 249.2m / Revenue TTM 4.09b)
Gross Margin = 28.93% ((Revenue TTM 4.09b - Cost of Revenue TTM 2.91b) / Revenue TTM)
Gross Margin QoQ = 23.87% (prev 28.19%)
Tobins Q-Ratio = 1.48 (Enterprise Value 15.5b / Total Assets 10.5b)
Interest Expense / Debt = 2.97% (Interest Expense 157.7m / Debt 5.31b)
Taxrate = 16.40% (78.6m / 479.4m)
NOPAT = 386.3m (EBIT 462.1m * (1 - 16.40%))
Current Ratio = 2.35 (Total Current Assets 4.81b / Total Current Liabilities 2.05b)
Debt / Equity = 1.56 (Debt 5.31b / totalStockholderEquity, last quarter 3.41b)
Debt / EBITDA = 8.03 (Net Debt 5.07b / EBITDA 631.4m)
Debt / FCF = 15.03 (Net Debt 5.07b / FCF TTM 337.4m)
Total Stockholder Equity = 2.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.46% (Net Income 249.2m / Total Assets 10.5b)
RoE = 10.09% (Net Income TTM 249.2m / Total Stockholder Equity 2.47b)
RoCE = 6.86% (EBIT 462.1m / Capital Employed (Equity 2.47b + L.T.Debt 4.27b))
RoIC = 4.40% (NOPAT 386.3m / Invested Capital 8.78b)
WACC = 6.83% (E(10.5b)/V(15.8b) * Re(9.03%) + D(5.31b)/V(15.8b) * Rd(2.97%) * (1-Tc(0.16)))
Discount Rate = 9.03% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -40.45 | Cagr: 3.38%
[DCF] Terminal Value 77.97% ; FCFF base≈306.3m ; Y1≈351.2m ; Y5≈516.8m
[DCF] Fair Price = 14.61 (EV 7.78b - Net Debt 5.07b = Equity 2.71b / Shares 185.2m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 97.32 | EPS CAGR: 13.72% | SUE: -2.30 | # QB: -1
Revenue Correlation: 82.47 | Revenue CAGR: 7.26% | SUE: 0.11 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.12 | Chg30d=-10.20% | Revisions=-50% | Analysts=10
EPS next Quarter (2026-09-30): EPS=1.38 | Chg30d=+1.37% | Revisions=-45% | Analysts=9
EPS current Year (2026-12-31): EPS=4.30 | Chg30d=-0.22% | Revisions=-8% | GrowthEPS=+22.6% | GrowthRev=+69.5%
EPS next Year (2027-12-31): EPS=5.38 | Chg30d=+0.21% | Revisions=-8% | GrowthEPS=+25.0% | GrowthRev=+5.2%
[Analyst] Revisions Ratio: -50%